Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | CCR5 | P51681 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 2/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30337155 | 0.93 | TACR1 (0.43) | THRBALDH1A1ACHETACR1HTR1A | |
| SCHEMBL24145803 | 0.89 | ENPP2 (0.48) | ENPP2THRBGRM2ALDH1A1CCR5 | |
| SCHEMBL30337246 | 0.88 | ENPP2 (0.47) | ENPP2THRBGRM2CCR5TACR1 | |
| SCHEMBL30337511 | 0.87 | KMT2A (0.43) | THRBACHELMNAHTR1A | |
| SCHEMBL30337582 | 0.81 | SMN1; SMN2 (0.45) | THRBTACR1HTR1A | |
| SCHEMBL30337060 | 0.81 | KMT2A (0.49) | ENPP2ACHEHTR1A | |
| SCHEMBL30337169 | 0.81 | HTR1A (0.48) | ACHEHTR1A | |
| SCHEMBL30337235 | 0.80 | HTR1A (0.43) | ENPP2THRBGRM2ALDH1A1LMNA | |
| SCHEMBL30337505 | 0.80 | ALDH1A1 (0.46) | ENPP2GRM2ALDH1A1CCR5MAPT | |
| SCHEMBL30337392 | 0.78 | ALDH1A1 (0.44) | ENPP2ALDH1A1CCR5LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916206-A | Novel compound and pharmaceutical composition for preventing or treating resistant cancer comprising same | 治愈医药社株式会社 | 2023-04-04 | — | — | CN | disclosed |